SCHEMBL29604367

SCHEMBL29604367

COC(=O)c1cc(F)ccc1CBr

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
FFAR4 Q5NUL3 1/20 0.42
PLA2G2A P14555 3/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41
ALDH1A1 P00352 2/20 0.41
LMNA P02545 2/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
TSHR P16473 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPC1 O15118 1/20 0.40
CASP3 P42574 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
PDK2 Q15119 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1435113 1.00 SLC6A4 (0.44) SLC6A4SLC6A3FFAR4PLA2G2ATP53
SCHEMBL7703503 0.87 FFAR4 (0.45) SLC6A4SLC6A3FFAR4PLA2G2AMAPT
SCHEMBL19245119 0.86 SLC6A4 (0.46) SLC6A4SLC6A3FFAR4PLA2G2AMAPT
SCHEMBL1773501 0.85 NPC1 (0.46) MAPTLMNANPC1RAB9ASMN1; SMN2
SCHEMBL19140616 0.85 TTR (0.49) SLC6A4SLC6A3PLA2G2AALDH1A1LMNA
SCHEMBL1470290 0.84 TSHR (0.52) MAPTALDH1A1LMNACYP1A2TSHR
SCHEMBL2076694 0.83 SLC6A4 (0.44) SLC6A4SLC6A3FFAR4PLA2G2AMAPT
SCHEMBL2292462 0.83 SLC6A4 (0.44) SLC6A4SLC6A3FFAR4PLA2G2AMAPT
SCHEMBL31757278 0.83 GABRA1 (0.40) CES2CES1
Hydrochloric Acid SCHEMBL1977404 0.82 SLC6A4 (0.43) SLC6A4SLC6A3FFAR4PLA2G2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4692092-A1 NOVEL COMPOUNDS WITH MTORC2-INHIBITORY ACTIVITY AND USES THEREOF Aliad Biopharma (KR) 2026-02-11 EP disclosed
WO-2024205377-A1 NOVEL COMPOUNDS WITH MTORC2-INHIBITORY ACTIVITY AND USES THEREOF 알리아드바이오파마 주식회사 2024-10-03 WO disclosed
EP-4277892-A1 SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS Les Laboratoires Servier (FR) 2023-11-22 EP disclosed
CN-116940552-A Spirocyclic hexane derivatives, pharmaceutical compositions containing them and their use as anti-apoptotic inhibitors 法国施维雅药厂 2023-10-24 CN disclosed
CN-112521387-B NLRP3 modulators 先天肿瘤免疫公司 2023-08-22 CN disclosed
WO-2022152705-A1 SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS LES LABORATOIRES SERVIER (FR) 2022-07-21 WO disclosed
CN-111057074-B Inhibitors of influenza virus replication and uses thereof 广东东阳光药业有限公司 2022-04-29 CN disclosed